BIODESIX, INC. Proceeds from Stock Options Exercised
BIODESIX, INC. (BDSX) reported Proceeds from Stock Options Exercised of $9.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-05
- BIODESIX, INC. proceeds from stock options exercised for the quarter ending 2026-06-30 was $8.00K.
- BIODESIX, INC. proceeds from stock options exercised for the quarter ending 2026-03-31 was $1.00K.
- BIODESIX, INC. proceeds from stock options exercised for the quarter ending 2024-12-31 was $6.00K, a 500.00% increase year-over-year.
- BIODESIX, INC. proceeds from stock options exercised for the quarter ending 2024-09-30 was $12.00K, a 300.00% increase year-over-year.
- BIODESIX, INC. proceeds from stock options exercised for fiscal 2024 was $25.00K, a 72.53% decline from fiscal 2023.
- BIODESIX, INC. proceeds from stock options exercised for fiscal 2023 was $91.00K, a 66.17% decline from fiscal 2022.
- BIODESIX, INC. proceeds from stock options exercised for fiscal 2022 was $269.00K, a 65.02% decline from fiscal 2021.
- BIODESIX, INC. proceeds from stock options exercised for fiscal 2021 was $769.00K, a 42.61% decline from fiscal 2020.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.00K 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-04 | |||
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.00K derived: sum of 2 quarters · filed 2026-02-26 | $22.00K derived: sum of 3 quarters · filed 2026-02-26 | $25.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $16.00K derived: sum of 2 quarters · filed 2025-11-03 | $19.00K 10-Q · filed 2025-11-03 | $20.00K derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $7.00K 10-Q · filed 2025-08-07 | $8.00K derived: sum of 3 quarters · filed 2025-08-07 | $11.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $3.00K 10-Q · filed 2025-05-13 | $4.00K derived: sum of 2 quarters · filed 2025-05-13 | $7.00K derived: sum of 3 quarters · filed 2025-05-13 | $88.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $4.00K derived: sum of 2 quarters · filed 2025-03-03 | $85.00K derived: sum of 3 quarters · filed 2025-03-03 | $91.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $84.00K derived: sum of 2 quarters · filed 2024-11-01 | $90.00K 10-Q · filed 2024-11-01 | $210.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $87.00K 10-Q · filed 2024-08-07 | $207.00K derived: sum of 3 quarters · filed 2024-08-07 | $264.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-08 | $126.00K derived: sum of 2 quarters · filed 2024-05-08 | $183.00K derived: sum of 3 quarters · filed 2024-05-08 | $200.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $177.00K derived: sum of 2 quarters · filed 2024-03-01 | $194.00K derived: sum of 3 quarters · filed 2024-03-01 | $269.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $74.00K derived: sum of 2 quarters · filed 2023-11-07 | $149.00K 10-Q · filed 2023-11-07 | $179.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $92.00K 10-Q · filed 2023-08-07 | $122.00K derived: sum of 3 quarters · filed 2023-08-07 | $182.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $75.00K 10-Q · filed 2023-05-11 | $105.00K derived: sum of 2 quarters · filed 2023-05-11 | $165.00K derived: sum of 3 quarters · filed 2023-05-11 | $369.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $90.00K derived: sum of 2 quarters · filed 2023-03-06 | $294.00K derived: sum of 3 quarters · filed 2023-03-06 | $769.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $264.00K derived: sum of 2 quarters · filed 2022-11-03 | $739.00K 10-Q · filed 2022-11-03 | $2.05M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $679.00K 10-Q · filed 2022-08-04 | $1.99M derived: sum of 3 quarters · filed 2022-08-04 | $2.01M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $475.00K 10-Q · filed 2022-05-11 | $1.79M derived: sum of 2 quarters · filed 2022-05-11 | $1.80M derived: sum of 3 quarters · filed 2022-05-11 | $1.80M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.33M derived: sum of 2 quarters · filed 2022-03-14 | $1.33M derived: sum of 3 quarters · filed 2022-03-14 | $1.34M 10-K · filed 2022-03-14 |
| 2020-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $14.00K derived: sum of 2 quarters · filed 2021-11-15 | $25.00K 10-Q · filed 2021-11-15 | $27.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $11.00K 10-Q · filed 2021-08-10 | $13.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $11.00K 10-Q · filed 2021-05-11 | $13.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $47.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $45.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |